Christopher P. Kalnin - 10 Nov 2025 Form 4 Insider Report for BKV Corp (BKV)

Role
Chief Executive Officer, Director
Signature
/s/ Kathleen Lenox, attorney-in-fact
Issuer symbol
BKV
Transactions as of
10 Nov 2025
Transactions value $
-$5,329,000
Form type
4
Filing time
12 Nov 2025, 11:44:39 UTC
Previous filing
05 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kalnin Christopher P Chief Executive Officer, Director 1200 17TH STREET, SUITE 2100, DENVER /s/ Kathleen Lenox, attorney-in-fact 12 Nov 2025 0001953932

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BKV Common Stock Sale -$2.62M -100K -6.46% $26.16 1.45M 10 Nov 2025 Direct F1, F2
transaction BKV Common Stock Sale -$2.71M -100K -6.9% $27.13 1.35M 11 Nov 2025 Direct F1, F3
holding BKV Common Stock 876K 10 Nov 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.